| First Author | Hascup KN | Year | 2020 |
| Journal | Sci Rep | Volume | 10 |
| Issue | 1 | Pages | 14503 |
| PubMed ID | 32879385 | Mgi Jnum | J:296403 |
| Mgi Id | MGI:6467167 | Doi | 10.1038/s41598-020-71587-6 |
| Citation | Hascup KN, et al. (2020) Hippocampal alterations in glutamatergic signaling during amyloid progression in AbetaPP/PS1 mice. Sci Rep 10(1):14503 |
| abstractText | Our previous research demonstrated that soluble amyloid-beta (Abeta)42, elicits presynaptic glutamate release. We hypothesized that accumulation and deposition of Abeta altered glutamatergic neurotransmission in a temporally and spatially dependent manner. To test this hypothesis, a glutamate selective microelectrode array (MEA) was used to monitor dentate (DG), CA3, and CA1 hippocampal extracellular glutamate levels in 2-4, 6-8, and 18-20 month-old male AbetaPP/PS1 and age-matched C57BL/6J control mice. Starting at 6 months of age, AbetaPP/PS1 basal glutamate levels are elevated in all three hippocampal subregions that becomes more pronounced at the oldest age group. Evoked glutamate release was elevated in all three age groups in the DG, but temporally delayed to 18-20 months in the CA3 of AbetaPP/PS1 mice. However, CA1 evoked glutamate release in AbetaPP/PS1 mice was elevated at 2-4 months of age and declined with age. Plaque deposition was anatomically aligned (but temporally delayed) with elevated glutamate levels; whereby accumulation was first observed in the CA1 and DG starting at 6-8 months that progressed throughout all hippocampal subregions by 18-20 months of age. The temporal hippocampal glutamate changes observed in this study may serve as a biomarker allowing for time point specific therapeutic interventions in Alzheimer's disease patients. |
